Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 15, 2008
Landmark trial provides new insight for physicians
-
Oct 15, 2008
Outcomes from the study of 22,000 patients with coronary artery disease continues to show impressive safety and efficacy data
-
Oct 14, 2008
New SYNTAX Score shows similar safety and efficacy outcomes for two thirds of study's patients
-
Oct 14, 2008
Company moves up Q3 earnings release date
-
Oct 14, 2008
TAXUS® Atom™ in more than 500 accounts Company opening new PROMUS™ accounts
-
Oct 13, 2008
Joint efforts will focus on intravascular ultrasound (IVUS)
-
Oct 13, 2008
Thursday and Friday of last week saw continued heavy trading in Boston Scientific's (NYSE: BSX) stock. As anticipated in the Company's October 9th...
-
Oct 12, 2008
Two-year pooled ARRIVE data showed the TAXUS Stent reduced clinical restenosis in patients with diabetes as effectively as in patients without diabetes
-
Oct 12, 2008
New coronary stent features thin struts designed for more uniform drug delivery
-
Oct 10, 2008
TAXUS Liberte drug eluting stent, launched in Europe and other international markets in 2005, to launch in U.S. next month